This week at BU:Medical technology forum on novel drug/device delivery

July 27th Forum: CIMIT Summer Education Series – Emerging Technologies and Applications for Therapeutic Delivery of Drugs and Molecules

4:00-6:00pm

Boston University Photonics Center

8 Saint Mary’s St., Boston

Colloquium Room, Room 906

For four weeks in July, the CIMIT Forum Summer Education Series offers attendees the opportunity to build an understanding of a new or important clinical or technical area.

Novel Drug Delivery and Drug/Device Combination Therapy will play an increasingly important role in future therapeutics, enhancing both safety and efficacy. Controlled, localized drug delivery holds the promise to remove some of the key challenges of current therapeutics: toxicity (often distant from the site of intended action), patient compliance, and targeting (the inability to achieve sustained concentrations of the active agent at the site of the disease).

The goal of the 2010 CIMIT Summer Education Series is to link current and evolving technologies with unmet clinical needs through a series of lectures by expert scientist and clinician leaders who are developing new technologies and translating them into clinical solutions. The course will highlight technologies ranging from targeted polymer-drug conjugates and nano-scale carriers to intracellular delivery of siRNA and clinical applications including infectious disease, inflammation/immunity, cancer, cardiovascular and neurological diseases. July 27: CLINICAL APPLICATIONS

Moderator: Jeffrey Borenstein, PhD, Charles Stark

Draper Laboratory

Novel Therapies for Cancer

Yolonda Colson, MD, PhD, BWH

Anesthesia and Critical Care Therapies

Daniel Kohane, MD, PhD, Children’s Hospital

There is no registration required to attend the CIMIT Summer Series and weekly CIMIT Forum.

For more information about the CIMIT Forum, contact

DeAnna Grosbaum, CIMIT, dgrosbaum@partners.org, 617-726-0797, or go to www.cimit.org.

Leave a Reply

Your email address will not be published. Required fields are marked *